The Psychological Consequences of the COVID-19 Pandemic in Adults Treated for Childhood Cancer.


Journal

Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503

Informations de publication

Date de publication:
06 06 2022
Historique:
received: 19 04 2022
revised: 30 05 2022
accepted: 31 05 2022
entrez: 23 6 2022
pubmed: 24 6 2022
medline: 25 6 2022
Statut: epublish

Résumé

Compared with the general population, childhood cancer survivors (CCS) could be at greater risk of psychological distress following the emergence of the COVID-19 pandemic. This cross-sectional study assessed the psychological consequences of COVID-19 on the mental health of CCS. In December 2020, we interviewed through an online self-report questionnaire, 580 5-year CCS participating in the French Childhood Cancer Survivor Study (FCCSS) cohort. We first compared the mental health score of CCS with that observed in the French general population of the same age and gender. Subsequently, we studied predictors of the mental health score of CCS. External comparisons revealed that the mental health score of CCS was similar to that of the general population. Among CCS, almost 42% stated that their psychological state had been worse during the lockdown. Predictors of poorer mental health included, among others, female gender, reporting a change in the occupational situation, having a relative who had been hospitalized or had died following COVID-19, and a greater perceived infection risk. Given the pre-existing vulnerability of some CCS to mental distress, the additional psychological consequences of COVID-19 in vulnerable survivors should receive attention from health care providers.

Sections du résumé

BACKGROUND
Compared with the general population, childhood cancer survivors (CCS) could be at greater risk of psychological distress following the emergence of the COVID-19 pandemic.
PURPOSE
This cross-sectional study assessed the psychological consequences of COVID-19 on the mental health of CCS.
DESIGN AND PARTICIPANTS
In December 2020, we interviewed through an online self-report questionnaire, 580 5-year CCS participating in the French Childhood Cancer Survivor Study (FCCSS) cohort.
METHODS
We first compared the mental health score of CCS with that observed in the French general population of the same age and gender. Subsequently, we studied predictors of the mental health score of CCS.
RESULTS
External comparisons revealed that the mental health score of CCS was similar to that of the general population. Among CCS, almost 42% stated that their psychological state had been worse during the lockdown. Predictors of poorer mental health included, among others, female gender, reporting a change in the occupational situation, having a relative who had been hospitalized or had died following COVID-19, and a greater perceived infection risk.
INTERPRETATION AND IMPLICATIONS
Given the pre-existing vulnerability of some CCS to mental distress, the additional psychological consequences of COVID-19 in vulnerable survivors should receive attention from health care providers.

Identifiants

pubmed: 35735436
pii: curroncol29060327
doi: 10.3390/curroncol29060327
pmc: PMC9221954
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4104-4116

Références

JAMA. 2013 Jun 12;309(22):2371-2381
pubmed: 23757085
Cancer. 2016 Apr 15;122(8):283-9
pubmed: 26991528
Eur J Heart Fail. 2019 Apr;21(4):509-518
pubmed: 30592114
J Clin Oncol. 2010 Apr 1;28(10):1740-8
pubmed: 20194864
Psychooncology. 2012 Jun;21(6):630-9
pubmed: 21425388
Cancer. 2021 Oct 1;127(19):3671-3679
pubmed: 34161601
Psychiatry Res. 2020 Nov;293:113419
pubmed: 32861098
J Clin Oncol. 2004 Mar 15;22(6):999-1006
pubmed: 15020603
Support Care Cancer. 2021 Jan;29(1):17-19
pubmed: 33052443
Psychooncology. 2020 Sep;29(9):1380-1383
pubmed: 32497353
Pediatr Blood Cancer. 2007 Jul;49(1):47-51
pubmed: 16755550
Gen Psychiatr. 2020 Sep 22;33(5):e100299
pubmed: 33083692
Soc Psychiatry Psychiatr Epidemiol. 2005 Apr;40(4):291-9
pubmed: 15834780
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
Circulation. 2016 Jan 5;133(1):31-8
pubmed: 26487757
Pediatr Hematol Oncol. 2016 Aug;33(5):295-313
pubmed: 27657743
J Pediatr Oncol Nurs. 2006 May-Jun;23(3):143-51
pubmed: 16624890
JCO Oncol Pract. 2021 Sep;17(9):e1258-e1269
pubmed: 33492984
Br J Psychiatry. 2021 Jun;218(6):326-333
pubmed: 33081860
J Gastrointest Cancer. 2021 Jun;52(2):499-507
pubmed: 33950368
J Clin Oncol. 2009 May 10;27(14):2396-404
pubmed: 19255309
Health Qual Life Outcomes. 2006 Oct 05;4:77
pubmed: 17022814
Urology. 2010 Nov;76(5):1224-30
pubmed: 20817270
Psychiatry Res. 2019 Apr;274:247-253
pubmed: 30818147
Lancet Oncol. 2012 Oct;13(10):1002-10
pubmed: 22921663
Aorta (Stamford). 2016 Aug 01;4(4):124-130
pubmed: 28097194
J Psychiatr Res. 2011 Aug;45(8):1027-35
pubmed: 21439576
Lancet Psychiatry. 2020 Oct;7(10):883-892
pubmed: 32707037
PLoS One. 2021 Jan 6;16(1):e0244419
pubmed: 33406085
Support Care Cancer. 2022 Jul;30(7):6263-6271
pubmed: 35460426
Pediatr Blood Cancer. 2021 Apr;68(4):e28943
pubmed: 33565259
Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):435-46
pubmed: 18268128

Auteurs

Asmaa Janah (A)

Université Paris Cité, INSERM, ECEVE, F-75010 Paris, France.

Nadia Haddy (N)

University of Paris-Saclay, F-94800 Villejuif, France.
Gustave Roussy, Department of Clinical Research, F-94800 Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800 Villejuif, France.

Charlotte Demoor-Goldschmidt (C)

University of Paris-Saclay, F-94800 Villejuif, France.
Gustave Roussy, Department of Clinical Research, F-94800 Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800 Villejuif, France.
CHU Angers, Paediatric Oncology Department, F-49100 Angers, France.
François Baclesse Centre, Radiotherapy Department, F-14000 Caen, France.

Nicolas Bougas (N)

Université Paris Cité, INSERM, ECEVE, F-75010 Paris, France.

Jacqueline Clavel (J)

Centre of Research in Epidemiology and Statistics, INSERM, F-94800 Villejuif, France.
National Registry of Childhood Cancer, Paul Brousse Hospital (AP-HP), F-94800 Villejuif, France.
Regional University Hospital Centre of Nancy (CHRU Nancy), F-54511 Vandœuvre-lès-Nancy, France.

Claire Poulalhon (C)

Centre of Research in Epidemiology and Statistics, INSERM, F-94800 Villejuif, France.
National Registry of Childhood Cancer, Paul Brousse Hospital (AP-HP), F-94800 Villejuif, France.
Regional University Hospital Centre of Nancy (CHRU Nancy), F-54511 Vandœuvre-lès-Nancy, France.

Brigitte Lacour (B)

Centre of Research in Epidemiology and Statistics, INSERM, F-94800 Villejuif, France.
National Registry of Childhood Cancer, Paul Brousse Hospital (AP-HP), F-94800 Villejuif, France.
Regional University Hospital Centre of Nancy (CHRU Nancy), F-54511 Vandœuvre-lès-Nancy, France.

Vincent Souchard (V)

University of Paris-Saclay, F-94800 Villejuif, France.
Gustave Roussy, Department of Clinical Research, F-94800 Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800 Villejuif, France.

Angela Jackson (A)

University of Paris-Saclay, F-94800 Villejuif, France.
Gustave Roussy, Department of Clinical Research, F-94800 Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800 Villejuif, France.

Leonie Casagranda (L)

CHU St Etienne, Paediatric Oncology Department, F-42055 St Etienne, France.
University of Lyon, University of Jean Monnet, INSERM, U 1059, F-42100 Saint-Étienne, France.

Claire Berger (C)

CHU St Etienne, Paediatric Oncology Department, F-42055 St Etienne, France.
University of Lyon, University of Jean Monnet, INSERM, U 1059, F-42100 Saint-Étienne, France.

Rodrigue Allodji (R)

University of Paris-Saclay, F-94800 Villejuif, France.
Gustave Roussy, Department of Clinical Research, F-94800 Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800 Villejuif, France.

Chiraz El Fayech (C)

Gustave Roussy, Department of Clinical Research, F-94800 Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800 Villejuif, France.
Gustave Roussy, Department of Children and Adolescents Oncology, F-94805 Villejuif, France.

Brice Fresneau (B)

Gustave Roussy, Department of Clinical Research, F-94800 Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800 Villejuif, France.
Gustave Roussy, Department of Children and Adolescents Oncology, F-94805 Villejuif, France.

Florent De Vathaire (F)

University of Paris-Saclay, F-94800 Villejuif, France.
Gustave Roussy, Department of Clinical Research, F-94800 Villejuif, France.
INSERM U 1018, CESP, Radiation Epidemiology Team, F-94800 Villejuif, France.

Agnes Dumas (A)

Université Paris Cité, INSERM, ECEVE, F-75010 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH